185 related articles for article (PubMed ID: 32344618)
1. Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections.
Isakova-Sivak I; Matyushenko V; Stepanova E; Matushkina A; Kotomina T; Mezhenskaya D; Prokopenko P; Kudryavtsev I; Kopeykin P; Sivak K; Rudenko L
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32344618
[TBL] [Abstract][Full Text] [Related]
2. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
3. Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.
Stepanova E; Krutikova E; Wong PF; Matyushenko V; Bazhenova E; Isakova-Sivak I; Rudenko L
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33513862
[TBL] [Abstract][Full Text] [Related]
4. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
[TBL] [Abstract][Full Text] [Related]
5. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.
Kotomina T; Korenkov D; Matyushenko V; Prokopenko P; Rudenko L; Isakova-Sivak I
Hum Vaccin Immunother; 2018; 14(12):2964-2970. PubMed ID: 30024831
[TBL] [Abstract][Full Text] [Related]
7. Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
Isakova-Sivak I; Stepanova E; Matyushenko V; Niskanen S; Mezhenskaya D; Bazhenova E; Krutikova E; Kotomina T; Prokopenko P; Neterebskii B; Doronin A; Vinogradova E; Yakovlev K; Sivak K; Rudenko L
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891306
[TBL] [Abstract][Full Text] [Related]
8. Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
Prokopenko P; Matyushenko V; Rak A; Stepanova E; Chistyakova A; Goshina A; Kudryavtsev I; Rudenko L; Isakova-Sivak I
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992084
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
[TBL] [Abstract][Full Text] [Related]
10. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
11. Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes.
Kotomina T; Isakova-Sivak I; Kim KH; Park BR; Jung YJ; Lee Y; Mezhenskaya D; Matyushenko V; Kang SM; Rudenko L
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33153089
[TBL] [Abstract][Full Text] [Related]
12. Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Stepanova E; Isakova-Sivak I; Mezhenskaya D; Niskanen S; Matyushenko V; Bazhenova E; Rak A; Wong PF; Prokopenko P; Kotomina T; Krutikova E; Legotskiy S; Neterebskii B; Ostroukhova T; Sivak K; Orshanskaya Y; Yakovlev K; Rudenko L
Virol J; 2024 Apr; 21(1):82. PubMed ID: 38589848
[TBL] [Abstract][Full Text] [Related]
13. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
14. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
15. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
16. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
17. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
18. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
Rudenko L; Isakova-Sivak I; Donina S
Vaccine; 2013 Oct; 31(42):4702-5. PubMed ID: 23988294
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
[TBL] [Abstract][Full Text] [Related]
20. Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
Lobby JL; Danzy S; Holmes KE; Lowen AC; Kohlmeier JE
J Immunol; 2024 Jan; 212(1):107-116. PubMed ID: 37982700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
